New Medical Devices Presented to Venture Capitalists and Industry Leaders at MassMEDIC Event
Revolutionary Treatments for Spinal Cord Injuries, Orthopedic Diseases and Infertility Featured at 10th Annual MedTech Investors Conference; Mass. Life Sciences Center’s Susan Windham-Bannister Provides Update on Life Sciences Initiative
Boston, Mass. (November 14, 2008) – More than 400 venture capitalists and medical device business leaders convened today to learn about the latest, cutting-edge technologies developed by the region’s emerging medical device companies. Twenty-five pre-venture, start-up firms had 10 minutes each to present their medical innovations to the group in the hopes of convincing them to help fund their devices. The presentations took place at the 10th Annual MassMEDIC MedTech Investors Conference at UMass Boston.
Among the range of new devices showcased was an infertility treatment device that offers comparable pregnancy rates to conventional treatments with lower risk, which can be performed in a physician’s office and at a fraction of the cost; a device that is surgically implanted within a primary spinal cord injury that mitigates secondary damage and stimulates neuroplastic repair processes; and a point-of-care diagnostic system that provides doctors with real-time, lab-quality results for the most frequently ordered blood tests.
The conference also featured presentations by Susan Windham-Bannister, president and CEO of the Massachusetts Life Sciences Center, the state agency implementing the new Life Sciences Initiative, and John Westwood of LEK Consulting, who presented an analysis of investment in area medical device companies.
Massachusetts is home to the nation’s second largest concentration of medical device manufacturing and development, with more than 225 manufacturers, 21,000 employees, annual shipments of $5.5 billion, and exports totaling $2.4 billion.
“More than ever, it is imperative that our medical device companies continue to play a major role in the global healthcare arena,” said Tom Sommer, President of MassMEDIC. “It’s not only critical to the advancement of medical technologies and treatment, it’s vital for the state’s economy.” Sommer continued, “Fostering the growth of these young, innovative companies leads to job growth and creation, and helps to maintain our position as a world leader in the medical device industry.”
Some of the technologies presented at the event included:
- A line of knee implants and instrumentation: that provides patients with a custom-fit, minimally invasive alternative to traditional knee replacement surgery; developed by ConforMIS, Inc. ofBurlington,Mass.
- A device that tests for genetic disorders before conception: for 50+ high penetrance genetic disorders. It’s an all-in-one, low cost device that can be administered by physicians in a clinical setting; developed by Good Start Genetics, Inc. (GSG) inBoston,Mass.
- A non-invasive detector that scans the body: and detects and measures pain, injury and dysfunction, and identifies the tissue types involved; developed by Signal Insight, Inc. of Freeport, Maine.
The following companies and organizations presented their technology and business plans at the conference:
|Avedro, Inc.(Waltham,MA)BioSense Technologies, Inc. (Woburn,MA)
Boston Neurofeedback Ctr., PC (Burlington,MA)
Confidisc Medical (Southampton,MA)
ConforMIS, Inc. (Burlington, MA)
Curative Biosciences, Inc. (Waltham,MA)
DxTech, LLC (Merrimack,NH)
EyeGate Pharmaceuticals, Inc. (Waltham,MA)
Flex Biomedical, Inc. (Brookline,MA)
Good Start Genetics, Inc. (Boston,MA)
Innoventions, Ltd. (Israel)
Institute for Pediatric Innovation, Inc. (Cambridge,MA)
|INVO Bioscience(Beverly,MA)InVivo Therapeutics, Inc. (Cambridge,MA)
IQuum, Inc. (Marlborough,MA)
NMT Medical, Inc. (Boston,MA)
Photon etc. Inc. (Montreal)
Sentien Biotechnologies (Cambridge, MA)
Signal Insight, Inc. (Freeport, ME)
Smart Surfaces, Inc. (Somerville, MA)
Soteira, Inc. (Natick,MA)
Tomophase Corporation (Burlington,MA)
VasoTech, Inc. (Lowell,MA)
ZymeQuest, Inc. (Beverly,MA)